Markets must be defined from consumers' view, US states say in GLP-1 antitrust case

The relevant market in antitrust litigation against Eli Lilly and Novo Nordisk over GLP-1 drugs should be defined from the perspective of consumers, the states of Texas and Louisiana said in...

Already a subscriber? Click here to view full article